Clinical trial Recruiting at 2 sites Interventional Ages 2 and up

See if a wireless thermal device can measure CSF shunt flow during daily activities and sleep

Official title: Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep

Run by Rhaeos, Inc. · NCT07050628 · Data updated 2026-11-12

A wireless thermal device is being tested to see if it can non-invasively monitor CSF shunt flow in people with hydrocephalus during everyday activities and sleep.

Quick facts

Study typeInterventional
Ages2 Years and up
SexAll
Enrollment28 (estimated)
SponsorRhaeos, Inc.
Industry-sponsored
Locations2 sites (Chicago, Illinois and 1 other locations)
StatusRecruiting
StartedNovember 10, 2025
Main results expectedAugust 31, 2026
Study endsJune 30, 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07050628 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and young adults aged 5 to under 22 years with an existing ventricular CSF shunt and palpable shunt over the clavicle suitable for device placement.

Probably not a fit

Individuals without a clearly palpable shunt or with exclusion criteria (e.g., depth >4 mm at measurement site) may not benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a wireless thermal anisotropy measurement device designed to non-invasively monitor cerebrospinal fluid (CSF) shunt flow. Participants with existing ventricular shunts will wear the device while going about daily activities and sleeping, with measurements taken over multiple sessions. Cohort A includes participants with stable shunt history and no recent revisions, while Cohort B includes those with a recent shunt revision and expected discharge within a few days. Safety, feasibility, and data quality will be assessed to determine if the device can reliably reflect shunt flow in real-life conditions.

Why it matters

Potential benefit: If successful, the device could provide a non-invasive way to monitor shunt function in real time and potentially reduce the need for invasive checks.

How similar studies have gone: Prior approaches using non-invasive thermal or sensing methods have shown promise in similar shunt-monitoring contexts but this exact device and protocol are novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Existing ventricular CSF shunt
2. (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure
3. (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date
4. Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device
5. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
6. Subject is at least 5 years old but \< 22 years old

Exclusion Criteria:

1. Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation
2. Presence of an interfering open wound or edema in the study device measurement region
3. Subject-reported history of serious adverse skin reactions to silicone-based adhesives
4. Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable
5. Investigator judges that the subject is unlikely to successfully take reliable measurements at home
6. Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance
7. Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
8. Prior enrollment in this study
9. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Where it's running

  • Rhaeos Inc.
    Chicago, Illinois, United States
    Recruiting
  • Virginia Commonwealth University Medical Center
    Richmond, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.